Concepedia

Susan Schumer

SS

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2005

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Beth Israel Deaconess Medical Center

Harvard University

Massachusetts General Hospital

Susan Schumer is an author at Dana-Farber Cancer Institute specializing in cancer therapeutics, oncology, and medicine.

Top concepts

Publications per year

2005–2024

11

Publications

11

BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

Daniel B. Costa, Balázs Halmos, Amit Kumar et al. · PLoS Medicine · 2007 · 486 citations · Full text

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

Panagiotis A. Konstantinopoulos, Su-Chun Cheng, Andrea E. Wahner Hendrickson et al. · The Lancet Oncology · 2020 · 227 citations · Full text

, , +6

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer

Panagiotis A. Konstantinopoulos, Weixiu Luo, Joyce F. Liu et al. · Journal of Clinical Oncology · 2019 · 211 citations · Full text

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

Joyce F. Liu, Niya Xiong, Susana M. Campos et al. · Journal of Clinical Oncology · 2021 · 187 citations

Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment

Susan Pories, David Zurakowski, Roopali Roy et al. · Cancer Epidemiology Biomarkers & Prevention · 2008 · 94 citations · Full text

1–5 of 11